Vanguard Group’s Thermo Fisher Scientific TMO Stock Holding History

Vanguard Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$13.7B	Buy	33,789,164 +309,207	+0.9%	+$125M	0.22%	73
2025 Q1	$16.7B	Buy	33,479,957 +230,382	+0.7%	+$115M	0.3%	47
2024 Q4	$17.3B	Buy	33,249,575 +196,864	+0.6%	+$102M	0.3%	44
2024 Q3	$20.4B	Buy	33,052,711 +323,867	+1%	+$200M	0.37%	37
2024 Q2	$18.1B	Sell	32,728,844 -366,947	-1%	-$203M	0.35%	38
2024 Q1	$19.2B	Buy	33,095,791 +117,353	+0.4%	+$68.2M	0.38%	35
2023 Q4	$17.5B	Buy	32,978,438 +217,700	+0.7%	+$116M	0.38%	37
2023 Q3	$16.6B	Buy	32,760,738 +180,618	+0.6%	+$91.4M	0.41%	35
2023 Q2	$17B	Sell	32,580,120 -13,754	-0%	-$7.18M	0.4%	34
2023 Q1	$18.8B	Buy	32,593,874 +59,198	+0.2%	+$34.1M	0.48%	30
2022 Q4	$17.9B	Buy	32,534,676 +367,766	+1%	+$203M	0.49%	31
2022 Q3	$16.3B	Buy	32,166,910 +406,844	+1%	+$206M	0.48%	29
2022 Q2	$17.3B	Buy	31,760,066 +302,067	+1%	+$164M	0.49%	29
2022 Q1	$18.6B	Buy	31,457,999 +354,211	+1%	+$209M	0.44%	32
2021 Q4	$20.8B	Buy	31,103,788 +137,635	+0.4%	+$91.8M	0.47%	28
2021 Q3	$17.7B	Buy	30,966,153 +252,708	+0.8%	+$144M	0.44%	30
2021 Q2	$15.5B	Sell	30,713,445 -138,634	-0.4%	-$69.9M	0.39%	43
2021 Q1	$14.1B	Sell	30,852,079 -145,302	-0.5%	-$66.3M	0.38%	41
2020 Q4	$14.4B	Sell	30,997,381 -236,414	-0.8%	-$110M	0.42%	39
2020 Q3	$13.8B	Sell	31,233,795 -302,223	-1%	-$133M	0.46%	35
2020 Q2	$11.4B	Sell	31,536,018 -591,318	-2%	-$214M	0.41%	44
2020 Q1	$9.11B	Buy	32,127,336 +939,639	+3%	+$266M	0.39%	47
2019 Q4	$10.1B	Buy	31,187,697 +181,024	+0.6%	+$58.8M	0.35%	53
2019 Q3	$9.03B	Buy	31,006,673 +335,688	+1%	+$97.8M	0.33%	52
2019 Q2	$9.01B	Buy	30,670,985 +378,260	+1%	+$111M	0.34%	49
2019 Q1	$8.29B	Buy	30,292,725 +348,642	+1%	+$95.4M	0.33%	57
2018 Q4	$6.7B	Buy	29,944,083 +672,988	+2%	+$151M	0.3%	62
2018 Q3	$7.14B	Buy	29,271,095 +347,836	+1%	+$84.9M	0.28%	65
2018 Q2	$5.99B	Buy	28,923,259 +380,215	+1%	+$78.8M	0.25%	71
2018 Q1	$5.89B	Buy	28,543,044 +503,548	+2%	+$104M	0.26%	66
2017 Q4	$5.32B	Buy	28,039,496 +486,809	+2%	+$92.4M	0.23%	73
2017 Q3	$5.21B	Buy	27,552,687 +952,293	+4%	+$180M	0.24%	67
2017 Q2	$4.64B	Buy	26,600,394 +629,093	+2%	+$110M	0.23%	78
2017 Q1	$3.99B	Buy	25,971,301 +695,079	+3%	+$107M	0.21%	83
2016 Q4	$3.57B	Buy	25,276,222 +470,887	+2%	+$66.4M	0.2%	91
2016 Q3	$3.95B	Buy	24,805,335 +568,629	+2%	+$90.4M	0.23%	75
2016 Q2	$3.58B	Buy	24,236,706 +247,812	+1%	+$36.6M	0.22%	81
2016 Q1	$3.4B	Buy	23,988,894 +504,248	+2%	+$71.4M	0.22%	84
2015 Q4	$3.33B	Buy	23,484,646 +519,908	+2%	+$73.7M	0.22%	79
2015 Q3	$2.81B	Buy	22,964,738 +440,524	+2%	+$53.9M	0.2%	88
2015 Q2	$2.92B	Buy	22,524,214 +357,874	+2%	+$46.4M	0.2%	92
2015 Q1	$2.98B	Buy	22,166,340 +677,984	+3%	+$91.1M	0.2%	91
2014 Q4	$2.69B	Buy	21,488,356 +740,663	+4%	+$92.8M	0.19%	100
2014 Q3	$2.52B	Buy	20,747,693 +271,459	+1%	+$33M	0.2%	97
2014 Q2	$2.42B	Buy	20,476,234 +1,295,631	+7%	+$153M	0.19%	95
2014 Q1	$2.31B	Buy	19,180,603 +2,192,851	+13%	+$264M	0.19%	93
2013 Q4	$1.89B	Buy	16,987,752 +304,065	+2%	+$33.9M	0.17%	113
2013 Q3	$1.54B	Buy	16,683,687 +410,132	+3%	+$37.8M	0.15%	129
2013 Q2	$1.38B	Buy	+16,273,555	New	+$1.38B	0.14%	130